Results 1 to 10 of about 1,686,484 (283)

Antiphospholipid antibodies are not elevated in patients with severe COVID-19 pneumonia and venous thromboembolism

open access: yesThrombosis Research, 2020
COVID-19 pneumonia could be associated with an increased risk of venous thrombosis. Antiphospholipid antibodies might be involved in thrombosis in COVID-19 patients.
Galeano Valle, Francisco   +5 more
core   +2 more sources

Churg–Strauss syndrome associated with antiphospholipid antibodies in a patient with recurrent myocardial and cerebral ischemia

open access: yesInternational Medical Case Reports Journal, 2012
Marino Paroli,1 Alessandro Polidoro,1 Simone Romano,1 Daniele Accapezzato21Department of Biotechnology and Medical-Surgical Sciences, 2Department of Internal Medicine and Medical Specialties, Sapienza University of Rome, Rome, ItalyAbstract: We report on
Paroli M   +3 more
doaj   +1 more source

Antiphospholipid antibody profile based obstetric outcomes of primary antiphospholipid syndrome: the PREGNANTS study [PDF]

open access: yesAmerican Journal of Obstetrics and Gynecology, 2017
BACKGROUND: Antiphospholipid syndrome is an autoimmune, hypercoagulable state that is caused by antiphospholipid antibodies. Anticardiolipin antibodies, anti-β2 glycoprotein-I, and lupus anticoagulant are the main autoantibodies found in ...
Gabriele Saccone   +2 more
exaly   +2 more sources

Prevalence of antiphospholipid antibodies in post-COVID and vaccinated individuals [PDF]

open access: yesInfectious Diseases and Tropical Medicine
OBJECTIVE: The outbreak of COVID-19 resulted mainly in respiratory disease; however, apart from that, the infection was presented with random systemic thromboembolic events.
S. Al-Rustum   +4 more
doaj   +2 more sources

Catastrophic antiphospholipid syndrome with eosinophilia mimicking hypereosinophilic syndromes with disseminated intravascular coagulation: a case report [PDF]

open access: yesJournal of Medical Case Reports
Background Catastrophic antiphospholipid syndrome is a rare variant of antiphospholipid syndrome where the presence of antiphospholipid antibodies and systemic inflammation leads to the rapid onset of multifocal thrombosis.
Hikari Ota   +6 more
doaj   +2 more sources

The Screening of Antiphospholipid Antibodies in Obstetric Antiphospholipid Syndrome-Like Events: A Regional Perspective

open access: yesGynecology Obstetrics & Reproductive Medicine, 2020
Objective: Obstetric antiphospholipid antibody syndrome is clinically recognized by adverse obstetric outcomes. To determine which antibody level best corresponds to the risk of these clinical outcomes is difficult.
Onder Onen, Fusun Gulizar Varol
doaj   +2 more sources

Cognitive Disorders And Antiphospholipid Antibodies

open access: yesAutoimmunity Reviews, 2017
Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)Cognitive disorders have frequently been described in the field of antiphospholipid syndrome (APS) and systemic lupus erythematosus (SLE).
Yelnik   +3 more
core   +3 more sources

Origin and pathogenesis of antiphospholipid antibodies

open access: yesBrazilian Journal of Medical and Biological Research, 1998
Antiphospholipid antibodies (aPL) are a heterogeneous group of antibodies that are detected in the serum of patients with a variety of conditions, including autoimmune (systemic lupus erythematosus), infectious (syphilis, AIDS) and lymphoproliferative ...
C.M. Celli, A.E. Gharavi
doaj   +2 more sources

The impact of hydroxychloroquine treatment on pregnancy outcome in women with antiphospholipid antibodies

open access: yesAmerican Journal of Obstetrics and Gynecology, 2016
Savino Sciascia   +2 more
exaly   +2 more sources

Added value of antiphosphatidylserine/prothrombin antibodies in the workup of thrombotic antiphospholipid syndrome: Communication from the ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies

open access: yesJournal of Thrombosis and Haemostasis, 2022
Diagnosis of antiphospholipid syndrome (APS) requires persistent presence of lupus anticoagulant (LAC), anticardiolipin (aCL) IgG/IgM, or anti‐β2 glycoprotein I (aβ2GPI) IgG/IgM antibodies.
A. Vandevelde   +7 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy